Automated insulin delivery (AID) systems, which integrate an insulin pump, a continuous glucose monitor (CGM), and a control algorithm, are now considered the gold standard for the management of type 1 diabetes (T1D).1 The gene discussed is INS; the disease is type 1 diabetes mellitus.